Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Asset Writedowns and Impairment (2022 - 2025)

InMed Pharmaceuticals has reported Asset Writedowns and Impairment over the past 4 years, most recently at $208737.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $208737.0; the TTM value through Dec 2025 reached $208737.0, changed N/A, while the annual FY2025 figure was $208737.0, 31.74% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $208737.0 at InMed Pharmaceuticals, roughly flat from $208737.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $576772.0 in Q3 2022 and troughed at -$529997.0 in Q2 2023.
  • A 4-year average of $110008.7 and a median of $170474.0 in 2023 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: crashed 83.89% in 2023 and later skyrocketed 392.21% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $576772.0 in 2022, then crashed by 70.44% to $170474.0 in 2023, then plummeted by 75.12% to $42408.0 in 2024, then soared by 392.21% to $208737.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for INM at $208737.0 in Q4 2025, $208737.0 in Q2 2025, and $42408.0 in Q2 2024.